93 related articles for article (PubMed ID: 10029699)
1. [Update on genetic markers of cancer].
Janoueix-Lerosey I; Delattre O
Bull Cancer; 1999 Jan; 86(1):15-21. PubMed ID: 10029699
[No Abstract] [Full Text] [Related]
2. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast cancer.
Robson ME; Boyd J; Borgen PI; Cody HS
Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
[No Abstract] [Full Text] [Related]
4. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
[TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; from BRCA1 OR BRCA2 to breast cancer].
Van den Ouweland AM
Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1228. PubMed ID: 11447881
[No Abstract] [Full Text] [Related]
6. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
[TBL] [Abstract][Full Text] [Related]
7. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
8. BRCA1, BRCA2 and their possible function in DNA damage response.
Kote-Jarai Z; Eeles RA
Br J Cancer; 1999 Dec; 81(7):1099-102. PubMed ID: 10584867
[No Abstract] [Full Text] [Related]
9. BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC).
Shen D; Vadgama JV
Oncol Res; 1999; 11(2):63-9. PubMed ID: 10489161
[TBL] [Abstract][Full Text] [Related]
10. Genetic tests forge ahead, despite scientific concerns.
Marshall A
Nat Biotechnol; 1996 Dec; 14(13):1642-3. PubMed ID: 9634835
[No Abstract] [Full Text] [Related]
11. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
Ost E; Illiger HJ
Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
[No Abstract] [Full Text] [Related]
13. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
14. Hereditary breast cancer: a review.
Arver B; Du Q; Chen J; Luo L; Lindblom A
Semin Cancer Biol; 2000 Aug; 10(4):271-88. PubMed ID: 10966850
[TBL] [Abstract][Full Text] [Related]
15. Are BRCA1- and BRCA2-associated breast cancers different?
Offit K
J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336
[No Abstract] [Full Text] [Related]
16. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
Kurtz JM
Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
[No Abstract] [Full Text] [Related]
17. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
Ligtenberg MJ; Hogervorst FB; Willems HW; Arts PJ; Brink G; Hageman S; Bosgoed EA; Van der Looij E; Rookus MA; Devilee P; Vos EM; Wigbout G; Struycken PM; Menko FH; Rutgers EJ; Hoefsloot EH; Mariman EC; Brunner HG; Van 't Veer LJ
Br J Cancer; 1999 Mar; 79(9-10):1475-8. PubMed ID: 10188893
[TBL] [Abstract][Full Text] [Related]
18. [Under what conditions should we propose a prophylactic mastectomy for a woman at risk?].
Gauthier-Villars M; Blandy C; Stoppa-Lyonnet D
Bull Cancer; 1999 Sep; 86(9):754-9. PubMed ID: 10576812
[No Abstract] [Full Text] [Related]
19. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
[TBL] [Abstract][Full Text] [Related]
20. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]